Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 2/3 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 3Stomach Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Prostatic Neoplasms 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Muscular Atrophy 1Mouth Neoplasms 1Lymphoma, Follicular 1Liver Neoplasms 1Hemorrhage 1Hematologic Neoplasms 1Glioblastoma 1Gallbladder Neoplasms 1Colonic Neoplasms 1Child Nutrition Disorders 1COVID-19 1

Interventions

Oxaliplatin 11Docetaxel 8Fluorouracil 6Capecitabine 6Trastuzumab 5Leucovorin 5Drug Therapy 5apatinib 4S 1 (combination) 4Tegafur 3Paclitaxel 3Nivolumab 3Irinotecan 3Cisplatin 3sintilimab 2disitamab vedotin 2Surgical Procedures, Operative 2Standard of Care 2Ramucirumab 2Hyperthermic Intraperitoneal Chemotherapy 2Epirubicin 2vinflunine 1toripalimab 1titanium silicide 1tislelizumab 1taxane 1polysaccharide-K 1pertuzumab 1margetuximab 1gimeracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Stomach Neoplasms × Standard of Care × Clear all
NCT07241715 2026-05-14

CONVERGENCE

National University Hospital, Singapore

Phase 2/3 Active not recruiting
300 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01655641 2012-10-16

TMGS

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Phase 2/3 Unknown
118 enrolled
Gastrointestinal

Colonic Neoplasms, Hemorrhage, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡